Affiliation:
1. EirMED, 10 Vsevolod Vishnevsky St., 197136 St. Petersburg, Russia
2. Pavlov Institute of Physiology, Russian Academy of Sciences, 6 Makarova Enb., 199034 St. Petersburg, Russia
Abstract
Spinal muscular atrophy (SMA) is an orphan disease characterized by the progressive degeneration of spinal alpha motor neurons. In recent years, nusinersen and several other drugs have been approved for the treatment of this disease. Transcutaneous spinal cord stimulation (tSCS) modulates spinal neuronal networks, resulting in changes in locomotion and posture in patients with severe spinal cord injury and stroke. We hypothesize that tSCS can activate motor neurons that are intact and restored by medication, slow the decline in motor activity, and contribute to the development of motor skills in SMA patients. Thirty-seven children and adults with SMA types 2 and 3 participated in this study. The median duration of drug treatment was over 20 months. The application of tSCS was performed during physical therapy for 20–40 min per day for ~12 days. Outcome measures were specific SMA motor scales, goniometry of contractured joints, and forced vital capacity. Significant increases in motor function, improved respiratory function, and decreased contracture were observed in both type 2 and 3 SMA participants. The magnitude of functional changes was not associated with participant age. Further studies are needed to elucidate the reasons for the beneficial effects of spinal cord electrical stimulation on SMA.
Funder
Ministry of Science and Higher Education of the Russian Federation
Reference54 articles.
1. Novikov, A., Maldova, M., Shandybina, N., Shalmiev, I., Shoshina, E., Epoyan, N., and Moshonkina, T. (2023). First Use of Non-Invasive Spinal Cord Stimulation in Motor Rehabilitation of Children with Spinal Muscular Atrophy. Life, 13.
2. Prevalence, Incidence and Carrier Frequency of 5q–Linked Spinal Muscular Atrophy—A Literature Review;Verhaart;Orphanet J. Rare Dis.,2017
3. Spinal Muscular Atrophy;Mercuri;Nat. Rev.,2022
4. Identification and Characterization of a Spinal Muscular Atrophy-Determining Gene;Lefebvre;Cell,1995
5. Diagnosis and Management of Spinal Muscular Atrophy: Part 1: Recommendations for Diagnosis, Rehabilitation, Orthopedic and Nutritional Care;Mercuri;Neuromuscul. Disord.,2018